The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Analysis of survival and objective response (OR) in patients with hepatocellular carcinoma in a phase III study of lenvatinib (REFLECT).
 
Masatoshi Kudo
Honoraria - Abbvie; Bayer; Bristol-Myers Squibb Japan; EA Pharma; Eisai; Gilead Sciences; Merck Serono; Merck Serono; MSD; Novartis; Pfizer; Taiho Pharmaceutical
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; MSD
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb Japan (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Otsuka (Inst); Taiho Pharmaceutical (Inst)
 
Richard S. Finn
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Genentech/Roche; Lilly; Merck; Novartis; Pfizer
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
 
Shukui Qin
No Relationships to Disclose
 
Kwang-Hyub Han
Research Funding - Bayer; Eisai; Kowa
 
Kenji Ikeda
Honoraria - Dainippon Sumitomo Pharma; Eisai
 
Ann-Lii Cheng
Honoraria - AstraZeneca; Bayer Yakuhin; Eisai; Genentech/Roche
Consulting or Advisory Role - AstraZeneca; Bayer Schering Pharma; Bristol-Myers Squibb; CSR Pharma; Eisai; Genentech/Roche; MSD; Novartis; Ono Pharmaceutical
 
Fabio Piscaglia
Honoraria - Bayer; Bracco Diagnostics; Eisai
 
Kazuomi Ueshima
Honoraria - Bayer
Consulting or Advisory Role - Eisai
 
Hiroshi Aikata
No Relationships to Disclose
 
Arndt Vogel
Honoraria - Amgen; Bayer; Bristol-Myers Squibb; Delcath Systems; Lilly; MSD; Novartis; Roche; Sanofi
Consulting or Advisory Role - Amgen; Baxalta; Bayer; Delcath Systems; Lilly; Novartis; Roche
Research Funding - Novartis
Travel, Accommodations, Expenses - Bayer; Ipsen; Roche
 
Carlos Lopez
Honoraria - Bayer; Daiichi Sankyo; Eisai; Lilly
Research Funding - Bayer; Daiichi Sankyo; Eisai; Lilly
 
Marc Pracht
No Relationships to Disclose
 
Zhiqiang Meng
No Relationships to Disclose
 
Bruno Daniele
Honoraria - Bayer; Bristol-Myers Squibb
Consulting or Advisory Role - Bayer; Eisai; Ipsen; Lilly; MSD
Travel, Accommodations, Expenses - Amgen; Bayer; Bristol-Myers Squibb; Celgene; Sanofi
 
Joong-Won Park
Honoraria - Bayer; Bristol-Myers Squibb
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Exelixis; Merck; Ono Pharmaceutical
 
Daniel H. Palmer
Honoraria - Bayer; Bristol-Myers Squibb; Eisai; Nucana
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Sirtex Medical
Research Funding - Bayer; Bristol-Myers Squibb; Nucana; Sirtex Medical
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Eisai; Nucana; Sirtex Medical
 
Corina E. Dutcus
Employment - Eisai
Leadership - Eisai
 
Toshiyuki Tamai
Employment - Eisai
 
Kenichi Saito
Employment - Eisai
 
Riccardo Lencioni
Consulting or Advisory Role - Bayer; BTG; Eisai; Guerbet
Research Funding - BTG